<code id='4EA8316A50'></code><style id='4EA8316A50'></style>
    • <acronym id='4EA8316A50'></acronym>
      <center id='4EA8316A50'><center id='4EA8316A50'><tfoot id='4EA8316A50'></tfoot></center><abbr id='4EA8316A50'><dir id='4EA8316A50'><tfoot id='4EA8316A50'></tfoot><noframes id='4EA8316A50'>

    • <optgroup id='4EA8316A50'><strike id='4EA8316A50'><sup id='4EA8316A50'></sup></strike><code id='4EA8316A50'></code></optgroup>
        1. <b id='4EA8316A50'><label id='4EA8316A50'><select id='4EA8316A50'><dt id='4EA8316A50'><span id='4EA8316A50'></span></dt></select></label></b><u id='4EA8316A50'></u>
          <i id='4EA8316A50'><strike id='4EA8316A50'><tt id='4EA8316A50'><pre id='4EA8316A50'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:95922
          After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

          WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

          But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

          advertisement

          The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Time to name cancers by genetics, not organ of origin, expert says
          Time to name cancers by genetics, not organ of origin, expert says

          Treatmentsforlungcancercanvarydependingonspecificmutation.Anoncologistarguesthecancersshouldhavediff

          read more
          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more

          Woodcock on FDA’s accelerated approval and her next chapter 

          JanetWoodcock,theFDA'sprincipaldeputycommissionerChipSomodevilla/GettyImagesWASHINGTON—It’stheendofa